FDA.reportPublic FDA data

Deferoxamine Mesylate

Product NDC
0409-2336
11-digit product format
004092336
Labeler code
0409
Product ID
0409-2336_4d8b8f53-ef32-400c-b911-acfbef4697ff
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Deferoxamine Mesylate
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Labeler
Hospira, Inc.
Application
ANDA076019
Marketing category
ANDA
Marketing start
2005-04-30
Marketing end
2021-09-01
Substance
DEFEROXAMINE MESYLATE
Active strength
500 mg/1
Pharmacologic classes
Iron Chelating Activity [MoA],Iron Chelator [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ef0d89c6-318e-9caf-5072-1f6976740df3Product name220171121

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0409-2336-01Deferoxamine Mesylate1 in 1 VIAL, SINGLE-USEINJECTION, POWDER, LYOPHILIZED,127
0409-2336-10Deferoxamine Mesylate4 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,427

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0409-2336-01EA - Each0409-2336b5f53891-68a0-4ea2-bd0a-e3b21691f85712020-02-13
0409-2336-10EA - Each0409-2336022a3185-e3ee-4d52-bf77-cfc4a0f12cf812012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DEFEROXAMINE MESYLATEACTIVE INGREDIENTV9TKO7EO6KDEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]11
DEFEROXAMINEACTIVE MOIETYJ06Y7MXW4DDEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0409-2336DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]23Legacy NDC, 2 package rows20240319_f9ab6b1c-98d0-4373-0e9b-b10cb4a67543.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1731345deferoxamine mesylate 2 GM InjectionPSNf9ab6b1c-98d0-4373-0e9b-b10cb4a6754327
1731350deferoxamine mesylate 500 MG InjectionPSNf9ab6b1c-98d0-4373-0e9b-b10cb4a6754327
1731345deferoxamine mesylate 2000 MG InjectionSCDf9ab6b1c-98d0-4373-0e9b-b10cb4a6754327
1731350deferoxamine mesylate 500 MG InjectionSCDf9ab6b1c-98d0-4373-0e9b-b10cb4a6754327
1731345deferoxamine mesylate 2 GM InjectionSYf9ab6b1c-98d0-4373-0e9b-b10cb4a6754327

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0409-2336-01004092336011 in 1 VIAL, SINGLE-USEHistorical
0409-2336-10004092336104 VIAL, SINGLE-USE in 1 CARTON (0409-2336-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-2336-01) 2005-04-302021-09-01NoNoCurrent